Literature DB >> 28376185

Circulating Biomarkers to Identify Patients With Resectable Pancreatic Cancer.

Michael Goggins1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28376185      PMCID: PMC6440276          DOI: 10.1093/jnci/djx004

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  23 in total

1.  A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.

Authors:  Seetharaman Balasenthil; Nanyue Chen; Steven T Lott; Jinyun Chen; Jennifer Carter; William E Grizzle; Marsha L Frazier; Subrata Sen; Ann McNeill Killary
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

2.  Detection and quantification of rare mutations with massively parallel sequencing.

Authors:  Isaac Kinde; Jian Wu; Nick Papadopoulos; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-17       Impact factor: 11.205

3.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

4.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

Authors:  Marcia Irene Canto; Ralph H Hruban; Elliot K Fishman; Ihab R Kamel; Richard Schulick; Zhe Zhang; Mark Topazian; Naoki Takahashi; Joel Fletcher; Gloria Petersen; Alison P Klein; Jennifer Axilbund; Constance Griffin; Sapna Syngal; John R Saltzman; Koenraad J Mortele; Jeffrey Lee; Eric Tamm; Raghunandan Vikram; Priya Bhosale; Daniel Margolis; James Farrell; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-12       Impact factor: 22.682

5.  Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.

Authors:  Sharon S Hori; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2011-11-16       Impact factor: 17.956

6.  Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.

Authors:  Jens Koopmann; C Nicole White Rosenzweig; Zhen Zhang; Marcia I Canto; David A Brown; Mark Hunter; Charles Yeo; Daniel W Chan; Samuel N Breit; Michael Goggins
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

7.  Serum biomarker panels for the detection of pancreatic cancer.

Authors:  Randall E Brand; Brian M Nolen; Herbert J Zeh; Peter J Allen; Mohamad A Eloubeidi; Michael Goldberg; Eric Elton; Juan P Arnoletti; John D Christein; Selwyn M Vickers; Christopher J Langmead; Douglas P Landsittel; David C Whitcomb; William E Grizzle; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

8.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

9.  Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.

Authors:  Alison P Klein; Kieran A Brune; Gloria M Petersen; Michael Goggins; Anne C Tersmette; G Johan A Offerhaus; Constance Griffin; John L Cameron; Charles J Yeo; Scott Kern; Ralph H Hruban
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  C T Mitchell; A Kamineni; W Palmas; M Cushman
Journal:  Atherosclerosis       Date:  2009-04-24       Impact factor: 5.162

View more
  1 in total

Review 1.  Reimagining the diagnostic pathway for gastrointestinal cancer.

Authors:  Greg Rubin; Fiona Walter; Jon Emery; Niek de Wit
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-07       Impact factor: 46.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.